ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Calcineurin Inhibitor (CNI) Nephrotoxicity Is Mediated by Defective Amp-Activated Protein Kinase (AMPK) Activation.

A. Zmijewska, J. Chen, J. Zmijewski, R. Mannon.

Medicine, UAB, Birmingham, AL.

Meeting: 2016 American Transplant Congress

Abstract number: D75

Keywords: Calcineurin, Immunosuppression, Nephrotoxicity, Oxidant stress

Session Information

Date: Tuesday, June 14, 2016

Session Name: Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Cyclosporine Nephrotoxicity Is Associated With Diminished Expression of Heat Shock Protein 27 (HSP27) and Loss of Claudin-2-Dependent Intercellular Adhesion
  • Genomic-Derived Markers to Identify Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.

Background: CNIs are potent immunosuppressant therapies, but associated with nephrotoxicity manifested by interstitial fibrosis and progressive graft dysfunction. AMPK is a major sensor and regulator of bioenergetics and redox homeostasis, and an essential regulator of mitophagy. Defective AMPK activation is associated with kidney injury in other disease models and augmenting AMPK ameliorates kidney injury. Herein, we investigate the potential link between CNI nephrotoxicity and defective renal bioenergetics.

Methods: In addition to proximal epithelial cells (PTECs), we studied a mouse model of CsA nephrotoxicity where animals were placed on 0.01% NaCl for 4 weeks, followed by CsA 30 mg/kg IP daily.

Results: Exposure of PTECs to CsA results in a potent oxidative stress response, generating cellular and mitochondrial ROS, detected by H2DCFDA-fluorescence and MitoSox superoxide specific probe, respectively (Fig 1A-B). Confocal microscopy reveals substantial alteration of the mitochondrial network, indicative of fission (Fig 1C). Oxidative stress was accompanied by significant alterations in mitochondrial structure, including diminished Electron Transport Chain complex I (3.1±0.1-fold; p<0.05) and complex IV (2.2±0.3-fold; p<0.05) compared to vehicle-treated cells. Further, CsA treatment results in submaximal activation of AMPK as detected by T172-AMPK phosphorylation (2.3±0.4-fold compared to veh; p<0.05), that is significantly augmented by the AMPK activator AICAR (4.9±0.7-fold compared to veh; p<0.05). In vivo, loss of AMPK activity is seen in both cortex and medulla of nephrotoxic mice as early as 2 weeks of CsA treatment (FIg 2). By 8 weeks, active-AMPK remains depressed and is associated with induction of myofibroblast activation as detected by induction of αSMA staining.

Conclusions: CsA treatment alters mitochondrial redox homeostasis with inadequate AMPK activation, associated myofibroblast activation, inciting a pro-fibrogenic renal milieu. Collectively, these results suggest that augmentation of the AMPK-mitochondrial pathway may ameliorate CNI-mediated renal injury. The available clinical AMPK activator, metformin, provides an exciting possibility for studies in man.

CITATION INFORMATION: Zmijewska A, Chen J, Zmijewski J, Mannon R. Calcineurin Inhibitor (CNI) Nephrotoxicity Is Mediated by Defective Amp-Activated Protein Kinase (AMPK) Activation. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Zmijewska A, Chen J, Zmijewski J, Mannon R. Calcineurin Inhibitor (CNI) Nephrotoxicity Is Mediated by Defective Amp-Activated Protein Kinase (AMPK) Activation. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/calcineurin-inhibitor-cni-nephrotoxicity-is-mediated-by-defective-amp-activated-protein-kinase-ampk-activation/. Accessed February 26, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
      • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
      • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

      Visit Our Partner Sites

      American Transplant Congress (ATC)

      Visit the official site for the American Transplant Congress »

      American Journal of Transplantation

      The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

      American Society of Transplantation (AST)

      An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

      American Society of Transplant Surgeons (ASTS)

      The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

      Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

      Privacy Policy

      loading Cancel
      Post was not sent - check your email addresses!
      Email check failed, please try again
      Sorry, your blog cannot share posts by email.
      This site uses cookies: Find out more.